Moraschini Vittorio, Mourão Carlos Fernando de Almeida Barros, Montemezzi Pietro, Kischinhevsky Ingrid Chaves Cavalcante, de Almeida Daniel Costa Ferreira, Javid Kayvon, Shibli Jamil Awad, Granjeiro José Mauro, Calasans-Maia Monica Diuana
Periodontology Department, Dental Research Division, School of Dentistry, Veiga de Almeida University, Rio de Janeiro 20271-020, Brazil.
Biotechnology Department, Universidade Federal Fluminense, Niteroi 24020-140, Brazil.
Healthcare (Basel). 2021 Mar 12;9(3):315. doi: 10.3390/healthcare9030315.
This systematic review (SR) aimed to evaluate implant survival rate, marginal bone loss (MBL), and biological/prosthetic complications of extra-short 4 mm dental implants. An electronic search without language or date restrictions was performed in five databases and in gray literature for articles published until August 2020. Prospective cohort studies and randomized clinical trials (RCTs) that evaluated the clinical performance of extra-short 4 mm dental implants were included. Studies were independently assessed for risk of bias using the Cochrane Collaboration's tool. The protocol of this SR was registered in the PROSPERO database under number CRD42019139709. Four studies were included in the present SR. There was no significant difference in implant survival rate ( = 0.75) between extra-short 4 mm and long implants. After 12 months of function, the extra-short implants had a significantly ( = 0.003) lower marginal bone loss (MBL) rate when compared to long implants. Extra-short implants had a lower number of biological and prosthetic complications when compared to long implants. After 12 months of follow-up, extra-short 4 mm dental implants placed in the mandible exhibit satisfactory clinical outcomes concerning implant survival rate and MBL when compared to longer implants, with a low number of biological and prosthetic complications. A higher number of RCTs with longer follow-up is necessary for the future.
本系统评价(SR)旨在评估4mm超短种植体的种植体存留率、边缘骨吸收(MBL)以及生物学/修复并发症情况。在五个数据库及灰色文献中进行了无语言或日期限制的电子检索,纳入截至2020年8月发表的文章。纳入了评估4mm超短种植体临床性能的前瞻性队列研究和随机临床试验(RCT)。使用Cochrane协作网工具对研究进行独立的偏倚风险评估。本SR的方案已在PROSPERO数据库中注册,注册号为CRD42019139709。本SR纳入了四项研究。4mm超短种植体与长种植体的种植体存留率无显著差异(P = 0.75)。在功能行使12个月后,与长种植体相比,超短种植体的边缘骨吸收(MBL)率显著更低(P = 0.003)。与长种植体相比,超短种植体的生物学和修复并发症数量更少。在随访12个月后,与更长的种植体相比,下颌植入的4mm超短种植体在种植体存留率和MBL方面表现出令人满意的临床结果,生物学和修复并发症数量较少。未来需要更多随访时间更长的RCT。